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C ardiomyopathy is a disease of un- known etiology in which presenting 
signs and symptoms result predominantly 
from dysfunction of the myocardium. A 
number of factors have been implicated in 
the causation of cardiomyopathy includ- 
ing alcohol,’ nutritional deficiency,2 the 
postpartal state,3 and virus infections.4*5 
Among these considerations is an under- 
lying immunologic disturbance, particu- 
larly as it may relate to endomyocardial 
fibrosis6 The role of autoimmunity in the 
pathogenesis of cardiomyopathy has been 
examined in a few previous studies.‘p8 We 
have reported recently an increased prev- 
alence of antiheart antibody in idiopathic 
hypertrophic subaortic stenosis (IHSS), 
but not in non-IHSS cardiomyopathy 
(CM).s The present study was designed to 
examine additional immunologic parame- 
ters in patients with cardiomyopathy. 
Materials and methods 
Forty-three patients with cardiomyopa- 
thy examined during 1968-69 were included 
in the present prospective study (Table I). 
Eight of these patients had IHSS and 35 
had CM. All patients with IHSS under- 
went cardiac catheterization and a sub- 
aortic pressure gradient was demonstrated 
in each. This gradient was altered in a 
typical manner with pharmacologic inter- 
ventions as well as with physiologic ma- 
neuvers. All patients in the CM group had 
cardiomegaly without discernible cause 
(coronary, rheumatic, congenital, or hyper- 
tensive cardiovascular disease). Associated 
risk factors predisposing to coronary artery 
disease, such as diabetes mellitus and 
hyperlipoproteinemia, were absent. Thirty 
of the 35 CM patients had the congestive 
form of the syndrome, while the remaining 
five presented with cardiomegaly without 
heart failure. Neither alcoholism nor mal- 
nutrition was felt to be solely responsible 
for heart disease in any patient. Thirteen 
of the CM group underwent cardiac cath- 
eterization, and a reduced cardiac output 
accompanied by an elevated left ventricular 
end-diastolic pressure was present in each. 
Coronary arteriograms were performed in 
four patients to exclude major coronary 
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Table I. Prevalence of HAB and ANA in study groups 
Diagnosis 
Sex Age HAB ANA 
- 
No. 
M F Mean Range No. ‘% No. y. 
Idiopathic hypertrophic 8 4 4 39 7-58 1 88 5 63 
subaortic stenosis (IHSS) 
Cardiomyopathy (CM) 35 28 7 43 22-58 6 17 1.5 43 
Rheumatic heart disease (RHD) 24 6 18 50 21-11 4 17 7 29 
Coronary artery disease (CAD) 17 13 4 55 24-76 0 0 2 12 
Control subjects (CS) 41 22 19 29 14-54 1 2 0 0 
artery disease. Six of the CM group died 
and idiopathic cardiomyopathy was con- 
firmed in each at necropsy. None of the 43 
patients was on procainamide or oral con- 
traceptives at the time of the study. Seven- 
teen patients with coronary artery disease 
(CAD) and 24 patients with chronic 
rheumatic heart disease (RHD) were ex- 
amined as “disease control” patients. 
Forty-one healthy subjects constituted the 
normal control group (CS). 
An indirect immunofluorescent technique 
was employed to detect antiheart antibody 
(HAB). Left ventricular tissue was ob- 
tained within 6 hours of death from infants 
who died of noncardiac causes. The tissue 
was frozen immediately in dry ice-iso- 
pentane and stored at -70’ C. Sections 
were cut on a cryostat at 4~, placed on 
microscope slides, and fixed in acetone for 
15 minutes. The sections were washed three 
times for 10 minutes each in isotonic phos- 
phate-buffered saline, pH 7.4. Serum to be 
tested was diluted 15 with buffer and was 
incubated on a tissue section for 4.5 minutes 
in a moist chamber. The sections were 
then rewashed and incubated for 30 min- 
utes with fluorescein-conjugated rabbit 
antihuman gamma globulins or conjugated 
rabbit antihuman IgG, IgA, or IgM. The 
slides were washed again and counter- 
stained quickly with eriochrome black, 
dried, and mounted in Elvanol. Normal 
serum, a positive serum that had been 
adsorbed with human heart muscle powder, 
and unlabeled antihuman gamma globulins 
were employed as controls in each experi- 
ment. 
The procedure for detection of anti- 
nuclear antibodies (ANA) was similar to 
the above method. Young mouse liver 
(male CBA/J) was the substrate. Serial 
dilutions of the serum were performed to 
determine end-point titer. Determination 
of immunoglobulin class of ANA was per- 
formed with rabbit antihuman IgG, IgA, 
or IgM, and conjugated sheep antirabbit 
gamma globulins. Controls included normal 
serum and a positive serum from a patient 
with systemic lupus erythematosus. Flu- 
orescent tests were read with a Zeiss ultra- 
violet microscope with a 200 watt mercury 
source. They were graded independently 
by two observers from 0 to 4+ on the basis 
of strength of fluorescence. A lf or greater 
response noted by both observers was re- 
quired for positivity. 
Gel diffusion to detect precipitating anti- 
bodies to nuclear constituents was done 
according to the method of Tan and 
Kunke1.n’ The latex fixation test for rheu- 
matoid factors was performed according to 
the method of Singer and Plotz.” Immuno- 
electrophoresis of whole serum to detect 
qualitative abnormalities in immunoglob- 
ulins was done according to the method of 
Scheidegger.rr Quantitative assay of serum 
for IgG, IgA, and IgM was performed 
according to the radial diffusion method of 
Mancini, Carbonara, and Heremand as 
modified by Fahey and McKelvey.14 The 
serologic test for syphilis (STS) was the 
method of the Venereal Disease Research 
Laboratory. Sequential tests for HAB and 
ANA were performed in seven patients 
with IHSS and in ten with CM during the 
two-year period. 
Statistical comparisons between vari- 
ables were made with the chi square test 
in a 2 by 2 table with Yates’ correction 
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Table II. Patterns of HAB and ANA juorescence 
HAB pattern ANA pattern 
Pre- Pre- Coarse 
Diagnosis dominantly dominantly Total Homo- PeripLral nodular Nucleolar Total 
sarco- subsarco- positive geneous and positive 
lemma1 lemmal reticular 
IHSS 2 5 7 2 - 5 
CM 4 2 6 6 5” : 3 1.5 
RAD 2 2 4 - 5 5 - 7 
CAD - - - 1 - 1 - 2 
cs 1 - 1 - - - - 0 
Table III. Prevalence of other immunologic parameters 
Diagnosis 








IHSS 8 1 0 0 1 
CM 35 2 1 1 12 1: 
*Number with serum concentration greater than mean plus 2 standard deviations of the mean. 
(Table IV). The probability of independ- 
ence was determined from tables.r5 A p 
equal to or less than 0.05 was considered 
significant. A rank-correlation test was 
used to analyze the data in Table VI. 
Student’s t test was used to compare mean 
concentrations of immunoglobulins. 
Results 
Only the sarcolemmal and subsarcolem- 
ma1 types of heart muscle staining were 
encountered in tests for HAB (Figs. 1 and 
2). Greater dilutions of test sera were re- 
quired to abolish sarcolemmal fluorescence. 
Various types and intensity of nuclear 
fluorescence were observed in tests for ANA 
(Fig. 3). More than one type of fluorescence 
was observed in serum in some cases, especi- 
ally with dilution. The patterns ob- 
served included the homogeneous, periph- 
eral, coarse nodular and reticular, and 
nucleolar (Table II). The predominant 
type of immunoglobulin associated with 
HAB was IgG, whereas that associated 
with ANA was IgM. 
The results of HAB and ANA determina- 
Table IV. Significant correla!ions between 




body Patient groups square p 7 
HAB IHSS vs. CM 
IHSS vs. RHD 
IHSS vs. CAD 
IHSS vs. CS 
ANA IHSS vs. CAD 
IHSS vs. CS 
CM vs. CS 
CM (< 40 yr.) vs. 









IgM IHSS + CM (females) vs. 5.594 0.018 
IHSS + CM (males) 
tions are summarized in Table I and the 
results of tests for other immunologic 
parameters are shown in Table III. Pre- 
cipitating antibody against nuclear con- 
stituents was not detected in any of the 
sera. Investigation for other evidences of 
immunologic aberration showed no sig- 
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Fig. 1. Example of a positive HAB test with serum from a patient with IHSS showing predominantly subsarco- 
lemma1 staining (A) and to a lesser degree sarcolemmal staining (B). 
Fig. 2. Example of a negative HAB test using serum of a control subject. Nonspecific autofluorescense may be 
seen (arrow). 
nificant increase in prevalence of rheuma- 
toid factors or in the test for syphilis. Serum 
concentrations of IgM were increased in 
women with cardiomyopathy in com- 
parison to men, and the mean level in men 
was significantly greater than that in nor- 
mal men of comparable age. Serum im- 
munoelectrophoresis showed no qualitative 
immunoglobulin abnormalities. Significant 
chi square correlations between the anti- 
body tests and the various patient groups 
are shown in Table IV. The relationship 
between functional class of disease (New 
York Heart Association) at the initial visit 
of the patient with IHSS and CM and 
with the antibody response is shown in 
Table V. 
Sera from seven patients with IHSS and 
ten patients with CM were re-examined 6 to 
12 months after the initial determination 
(Table VI). Of seven patients with IHSS 
initially positive for HAB, four continued 
to be positive. The functional class re- 
mained unchanged in the four patients in 
whom HAB persisted. Follow-up ANA tests 
done on the seven patients with IHSS were 
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Fig. 3. ExampIe of a positive ANA test using serum from a patient with cardiomyopathy, showing a homo- 
genous pattern of fluorescence. 
Table V. Relationship between functional class and prevalence of HAB and ANA in fiatients 




No. +HAB +ANA* No. +HAB -fANA 
IV 1 1 1 9 0 3 
III 4 4 4 14 4 7 
II 1 1 0 9 2 4 
I 2 1 0 3 0 1 
*Significant correlation. Chi square = 4.3022; p < 0.05. 
all negative save one. Of four patients in 
the CM group initially positive for HAB, 
three were negative on follow-up examina- 
tion. Two of these three patients improved 
clinically and one deteriorated during the 
interim. ANA were still positive in two of 
the three initially positive patients. There 
was no change from negative to positive 
status with respect to HAB or ANA in the 
follow-up study in the CM group. 
Discussion 
These studies indicate that in IHSS the 
prevalence of HAB is significantly in- 
creased (Table IV). The prevalence of ANA 
in the IHSS patients was similarly in- 
creased compared to the CS and CAD 
patients, but was not increased compared to 
the CM and RHD groups. An autoimmune 
disturbance in the basic disease process 
might be responsible, although investiga- 
tion for other evidence of immunologic 
aberration in these patients showed no 
significant increase in rheumatoid factors, 
in precipitating antibodies to nuclear con- 
stituents, or in the test for syphilis. The in- 
creased prevalence of HAB in the IHSS 
group parallels that observed in acute rheu- 
matic fever, particularly in those patients 
with associated carditis.lsJ7 The numerous 
bizarre-shaped nuclei with perinuclear halos 
along with the whorl formation of the 
muscle fibers, described as being fairly 
distinctive histologic features in IHSS,l* 
may account for some of these factors, such 
as the positive ANA. In the initial study 
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Table VI. Results of initial and follow-up study of functional class, HAB, and ANA in 8 
patients with IHSS and 10 patients with CM. 
Initial study Follow-up study 
-- -- -- 
Functional Functional 
class HAB ANA class HAB ANA 
Patients with IHSS: 
w. L. IV* 4+* 3+* II 0 0 
M. 0. III 4f 2+ III 2-b 2+ 
H. G. III 2+ If III 1+ 0 
B. 0. III 2+ 1+ II 0 0 
V. D. III 2+ 2+ II 0 0 
E. S. II 2+ 0 II 1+ 0 
FE? I I 0 1 + 0 I 1+ 0 









III 2+ 3+ II 0 0 
III 2+ 3+ II I f  I f  
III 1+ 0 IV 0 0 
III 0 1 + 0 1+ II II 0 0 1+ 
III 0  0 III II 0 0  
II 0 0 III 0 0 
II 0 0 II 0 0 
I 0 0 I 0 0 
*Rank-correlation (r.) for any one variable against another variable is significant with a p < 0.005. 
of IHSS, there was an association between 
functional class and degree of positivity of 
HAB and ANA (Tables V and VI). How- 
ever, this relationship did not obtain in the 
folIow-up study as positivity to both HAB 
and ANA did not remain constant. 
The presence of HAB in cardiomyopathy 
has been reported by several investiga- 
tors,‘,8Jg but its significance remains unde- 
fined. Detection of HAB lacks specificity 
from a pathogenic standpoint or as a diag- 
nostic test because of its occurrence in 
other forms of heart disease in frequencies 
equal to or even higher than in cardio- 
myopathy.20,21 Most authors surmise that 
it represents a consequence of cardiac in- 
jury. Camp and associates* did not find 
significant increases in the prevalence of 
HAB, rheumatoid factors, thyroid anti- 
body, microsomal antibodies, or other 
immunologic abnormalities in their cardio- 
myopathy patients. They concluded that 
autoimmune mechanisms were not re- 
sponsible for the disease in the majority 
of patients. Possibly HAB may appear in 
the circulation in the course of illness and 
not persist or may appear early in disease 
and disappear with progression. One pa- 
tient in our study whose serum was positive 
for HAB initially became negative as his 
disease progressed to a fatal outcome. It is 
noteworthy that none of the nine patients 
in Functional Class IV had HAB. Heart 
obtained at necropsy from two patients 
in Class IV had extensive bound gamma 
globulin.22 HAB may be adsorbed selec- 
tively to heart and not be detectable in the 
serum in clinically advanced disease. San- 
ders and Ritts23 found gamma globulin in 
the hearts of five of nine patients with 
cardiomyopathy and in hearts of two of 16 
control subjects. Neither of these latter 
two patients had evidence of heart disease. 
None of 16 control subjects had gross 
pathologic evidence of myocardial disease. 
Van der Geld and colleagues6 showed im- 
munohistologic and serologic evidence of 
autoimmune disturbances in endomyo- 
cardial fibrosis. The distribution of bound 
gamma globulin in the hearts of these 
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patients was similar to that observed by 
Kaplan and co11eagues24~2s in hearts of 
patients with rheumatic heart disease. 
The presence of ANA is considered to be 
an important feature of autoimmune dis- 
ease. Positive tests for this antibody may 
also follow administration of certain drugs, 
including procainamidezs and oral con- 
traceptives .21 None of our patients was on 
these drugs. ANA also increases with age. 
In this laboratory 21 per cent of 89 indi- 
viduals over 70 years of age were found to 
have ANA. Only four sera with positive 
ANA were found in 264 children under 14 
years of age from the same study.2S Aging 
may be a contributor to ANA positivity in 
the CM group as the prevalence of ANA 
was significantly greater in patients over 
40 years of age. Similarly, age rather than 
an underlying autoimmune disturbance 
may account for increased ANA positivity 
in the CAD group. The average age of the 
two male patients with positive ANA in 
this group was 69 years while that of the 
15 patients with negative ANA was 54 
years. Evidence that aging is not the sole 
contributor to ANA positivity is provided 
by the fact that the prevalence of ANA 
was increased significantly in the IHSS 
group compared to the CAD group despite 
the lower mean age of the former. The 
higher incidence of ANA in the RHD group 
compared to the CS group may be related 
to autoimmune mechanisms incited in 
susceptible individuals by streptococcal 
antigens capable of cross-reacting with 
heart muscle.2g Of interest is the increased 
frequency of ANA in our female patients 
with both forms of cardiomyopathy (Table 
V). A seemingly increased tendency for 
women to develop autoimmune disease 
may be partially responsible. The increase 
in IgM concentrations in women may be 
related in part to the normally higher mean 
level in this sex. This observation of Butter- 
worth and associates30 was confirmed in 
studies of our normal control groups. 
Summary 
The prevalence of HAB and ANA was 
determined in eight patients with idiopathic 
hypertrophic subaortic stenosis (IHSS) 
and 35 patients with cardiomyopathy 
(CM). HAB was found in 88 per cent of 
patients with IHSS and in 17 per cent of 
those with CM. AntinucIear antibody was 
found in 63 per cent of patients with IHSS 
and 43 per cent of those with CM. Aging 
alone was not responsible for the high 
prevalence of ANA in the former group, 
but may be partly so in the latter. There 
was an increased tendency for women in 
both groups to have ANA. An increased 
serum concentration of IgM was also ob- 
served in women in the IHSS and CM 
groups. Serum concentrations of IgG and 
IgA, precipitating antibodies to nuclear 
constituents, rheumatoid factors, and a 
positive serologic test for syphilis were not 
increased in patients with idiopathic car- 
diomyopathy. Positivity to HAB and ANA 
did not remain constant and was not pres- 
ent frequently in sera in follow-up studies 
of these patients. No instance of a negative 
test becoming positive was recorded for 
either HAB or ANA. The high prevalence 
of ANA in patients with IHSS and CM 
and an increased prevalence of HAB in 
patients with IHSS may suggest that an 
autoimmune disturbance is operative in 
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